to radiation necrosis. The incidence of RIICs has been reported in the range of 16%-62%, with symptomatic RIICs ranging from 3.7% to 10.8%, and permanent deficits ranging from 1% to 5.1%. 1, 3, 5, 6 Although often reported in the scientific literature, there are limited systematic studies that have been conducted to investigate the incidence and clinical implications of RIICs. The present study attempts to evaluate the incidence and severity of RIICs following GKS for AVMs, and the clinical manifestations associated with RIICs. Factors affecting the presence and severity of RIICs are also analyzed.
Methods

Gamma Knife Surgical Technique
The details of the GKS procedures for AVMs performed at our center have been previously reported.
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The Leksell Gamma Knife Unit model U (Elekta) was used from May 1989 to July 2001, and the model C was used from July 2001 to September 2009. The Gamma Knife Perfexion model was used after September 2009. Stereotactic biplane angiography was available for nidus definition and dose planning prior to 1991. Since 1991, stereotactic MRI was routinely used as a supplement to enhance the spatial accuracy of angiography for treatment planning. Kula software (Elekta) was used for dose planning until June 1994, which was then replaced with Gamma Plan software (Elekta).
Patient Population and Postradiosurgical Follow-Up
The Institutional Review Board approved use of the patient data. A total of 1400 patients with cerebral AVMs were treated with GKS at the University of Virginia from 1989 to 2009. Ninety-one patients were completely lost to follow-up. Of the remaining 1309 patients, there were 690 males and 619 females with a median age of 34.3 years (range 3-82 years; Table 1 ). One hundred seventy-nine patients underwent a second GKS and 12 patients underwent a third GKS for a residual AVM nidus. Postradiosurgical clinical status and imaging follow-up were available following 1500 GKS procedures.
Earlier at our center, patients underwent a rigorous follow-up protocol with yearly angiography. With the introduction of MRI, patients underwent MRI at 6-month intervals for the first 2 years, and then yearly afterward. When there was no nidus visible on MRI, patients underwent angiography to confirm obliteration of the nidus. All of the images were analyzed by both a neurosurgeon and a neuroradiologist.
Of the 1500 GKS procedures, 74 were performed before MRI follow-up was available. The remaining 1426 GKS procedures with postradiosurgical MRI were included in the present study. The median duration between GKS and last MRI follow-up was 42.7 months (range 2-240 months).
Arteriovenous Malformation Characteristics and Treatment Parameters
In the present study, AVM nidi that underwent a second or third GKS were considered a distinct nidus and (Table 1) . Of note, 63 nidi that initially presented with symptoms other than a hemorrhage ruptured in the time between the diagnosis and GKS. In total, 749 nidi (52.5%) had ruptured before GKS. One hundred fifty-four AVM nidi (10.8%) had been partially resected. Three hundred eighty-nine nidi (27.3%) had been partially embolized.
The locations of the AVM nidi are detailed in Table  1 . Four hundred seventy-five nidi were located in noneloquent areas and 951 in eloquent areas. The venous drainage was superficial only in 688 nidi, deep only in 550, and both in 188. The median nidus volume at the time of GKS was 2.8 ml (range 0.1-29.4 ml). The SpetzlerMartin grading at the time of GKS was Grade I nidi in 242, Grade II in 439, Grade III in 604, Grade IV in 129, and Grade V in 12.
The GKS treatment parameters were as follows: median maximum dose of 40 Gy (range 10-56 Gy), median margin dose of 21 Gy (range 5-36 Gy), median isodose line at 50% (range 30%-95%), and a median of 3 isocenters (range 1-22; Table 1 ).
Radiation-Induced Imaging Changes
Radiation-induced imaging changes were defined as newly developed increased T2 signal surrounding the treated AVM nidi following GKS. A grading system was developed to categorize the severity of RIIC. Grade I RIICs were defined as mild imaging changes with a thickness of increased T2 signal less than 10 mm surrounding the treated nidi, imposing no mass effect. Grade II RIICs were moderate imaging changes with increased T2 signal of 10 mm or greater, with some mass effect causing effacement of the sulci or compression of the adjacent ventricles. Grade III RIICs were severe imaging changes that caused midline shift of the brain.
Statistical Analysis
All statistical analyses were performed using the statistical software package SPSS (version 13.0). Univariate and multivariate logistic regression were used to analyze factors potentially affecting the occurrence of RIICs. Factors examined include sex; age at GKS; history of preradiosurgical hemorrhage, embolization, or resection; location of nidi (lobar vs deep, noneloquent vs eloquent); AVM volume; margin dose; maximum dose; isodose; number of isocenters; venous drainage (superficial and mixed venous drainage vs deep only); and number of draining veins (single vs multiple). In the subgroup of patients with postradiosurgical RIICs, the same statistical methods were used to evaluate the factors mentioned above and their association with the severity of RIICs (Grade I vs Grades II/III). The same factors and the severity of RIICs were analyzed for the presence or absence of neurological deficits in the subgroup of nidi that presented with RIICs. Factors significant for univariate analysis were entered into a multivariate analysis. A probability value of less than 0.05 was used as the limit for statistical significance.
Results
Incidence and Severity of RIICs, and Associated Neurological Symptoms
Of the 1426 Gamma Knife procedures, 482 nidi (33.8%) developed RIICs and 944 nidi (66.2%) did not ( Fig. 1) . Two hundred eighty-one (58.3%) were Grade I (Fig. 2) , 164 (34%) were Grade II (Fig. 3) , and 37 (7.7%) were Grade III (Fig. 4) . The median time from GKS to the development of RIICs was 13 months (range 2-124 months). In 84 patients, the increased T2 signal remained visible on their last follow-up MR image. Of the remaining 398 patients, the RIICs disappeared completely within 2 to 128 months (median 22 months) following the development of RIICs.
The RIICs were asymptomatic in 360 (74.7%). The overall incidence of symptomatic RIICs following GKS was 8.6% (122 of 1426 procedures). Headache only occurred in 33 cases, seizures in 14, and neurological deficits in 67. Three patients had headache and neurological deficits, 2 experienced headache and seizures, and 3 had seizures and neurological deficits. Forty-seven (16.7%) of 281 nidi with Grade I, 52 (31.7%) of 164 nidi with Grade II, and 23 (62.2%) of 37 nidi with Grade III RIICs were symptomatic.
In total, 73 patients (5.1%) experienced neurological deficits following the development of RIICs. Four of these patients had cranial nerve palsies, 4 had visual field deficits, 3 had dysphasia, 53 had hemiparesis, 4 had cerebellar symptoms, and 5 had altered mental status. Most of these symptoms were reversible. Twenty-six patients (1.8%) had permanent deficits and typical findings of radiation necrosis according to imaging (enhancing lesions with a central area of necrosis; Fig. 5 ). 8 None of our patients underwent surgery for RIICs.
Predicting Factors for Presence and Severity of RIICs, and Associated Neurological Deficits
On univariate analysis, old age (p = 0.048), large nidus (AVM volume; p = 0.001), low margin dose (p = 0.039), nidi without prior surgery (p < 0.001), nidi without prior hemorrhage (p < 0.001), and nidi with a single draining vein (p < 0.001) were associated with a higher risk of RIICs (Table 2) . On multivariate analysis, a negative history of prior surgery (p < 0.001), a negative history of hemorrhage (p < 0.001), increasing nidus volume (p = 0.006), and a single draining vein (p < 0.001) were associated with an increased risk of RIICs.
In terms of severity of RIICs, old age (p = 0.033) and large nidus volume (p = 0.039) were more likely to present as Grade II/III RIICs on univariate analysis. These 2 factors remained significant after multivariate analysis (Table 3) .
On univariate analysis, nidi without prior embolization (p = 0.003), located in eloquent (p = 0.012) or deep (p = 0.026) regions of the brain, with exclusively deep venous drainage (p = 0.014) were more likely to have symptomatic RIICs. Extensive RIICs (p < 0.001) were also more likely to cause neurological deficits. On multivariate analysis, a negative history of preradiosurgical embolization (p = 0.017), eloquent locations (p = 0.034) and Grade II/III RIICs (p < 0.001) were associated with a higher risk of clinical symptoms following the development of RIICs (Table 4) .
Radiation-Induced Imaging Changes in Initial and Repeated GKS
No follow-up MRI was available following repeated GKS in 13 procedures. Of the remaining 178 repeat procedures, RIICs developed in 56 nidi (31.5%). The incidence of RIICs following the initial GKS was 34.1% (426/1248). There was no statistically significant difference in the incidence of RIICs following repeated or initial GKS (p = 0.499). Of the 56 RIICs following repeated procedures, 31 (55.4%) were Grades II or III. Of the 426 RIICs after initial GKS, 169 (39.7%) were Grades II or III. The incidence of moderate to severe RIICs was higher following repeated GKS (p = 0.03). The incidence of symptomatic RIICs after repeated GKS was 21.4% (12/56), comparable to the incidence of 25.8% (110/426) after initial GKS (p = 0.518).
Radiation-Induced Imaging Changes and Nidi Obliteration Rate
The end results of obliteration were based on angiograms or MRI. One hundred and forty GKS procedures with follow-up shorter than 2 years were excluded from the analysis. Among the remaining 1286 procedures, 280 (62.8%) of 446 procedures that developed RIICs resulted in a total obliteration of the nidi. Of the 840 procedures without RIICs, 438 (52.1%) resulted in a total obliteration of the nidi, a statistically significant difference (p < 0.001). Compared with the total obliteration rate of 52.1% (438/840) in nidi without RIICs, 58.4% (150/257) of nidi with Grade I RIICs were obliterated, and 68.8% (130/189) of nidi with Grade II/III RIICs were obliterated (p < 0.001).
Discussion
Mechanisms of RIICs
The pathophysiological mechanisms of RIICs are not completely understood. Direct radiation injury of glial cells, especially oligodendroglia, may lead to demyelination and white matter degeneration. 17 Endothelial cell damage and release of cytokines followed by breakdown of the blood-brain barrier can cause brain edema.
7 Release of antigens following glial and endothelial cell damage could result in an autoimmune reaction.
14 Additionally, radiation damage to lipid membranes can generate free radicals that cause membrane dysfunction and cell death.
12 All of these processes might present themselves as RIICs on imaging.
In general, radiation injuries are related to treatment volume, radiation dose, treatment fractions, and interval of fractions. In the setting of a single-dose radiosurgical procedure, volume and dose undoubtedly affect the incidence of radiation injuries. Taking both volume and dose into consideration, 10-or 12-Gy volumes have been reported to predict the risk of RIICs following radiosurgery for AVMs. 1, 9, 16 Nonetheless, it is not unusual to observe patients developing far more extensive RIICs beyond 10-or 12-Gy volumes. Furthermore, RIICs occurred in a greater proportion of AVMs than in patients with tumors. Therefore, focal radiation effects alone could not explain all the RIICs, and at least in some cases RIICs might be vascular in origin. A vascular insult with subsequent ischemia might lead to glial loss, edema, or even radiation necrosis.
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The typical response of AVMs to radiosurgerynamely reactive proliferation of endothelial cells, accu- mulation of subendothelial matrix, hyaline deposition, and thrombus formation of the vascular channels-can occur in arteries, which might not be related to the AVMs and not within the planned targeting field. 20 The ischemic insults following occlusion of non-AVM-related arteries might cause RIICs far beyond the location of the nidi.
In additional to arterial injury, thrombosis of the draining vein could contribute to development of RIICs. We recently published a paper on a series of patients who developed RIICs with thrombosis and occlusion of the draining veins before obliteration of the nidi. 22 Patients with venous thrombosis tended to present with more extensive brain edema. Occlusive hyperemia, which radiographically presents with increased T2 signal, can develop during the obliteration process in which premature thrombosis of draining veins impaired the venous drainage of the nidus and white matter. 22 This phenomenon tends to occur in AVMs with a single draining vein.
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Risk Factors of RIICs
In the present series, AVMs that bled or had been partially resected were less likely to develop RIICs. A relatively healthy brain that had not been affected by a prior hemorrhage or surgery appeared to be more reactive to radiosurgery. Although hemosiderin has been reported as a radiosensitive agent and considered the cause of RIICs after GKS for cavernous malformations, we did not observe a higher risk of RIICs in AVMs with a prior hemorrhage. Nevertheless, very few of our patients with AVMs underwent GKS in acute or subacute stages after bleeding.
Most patient series that evaluate the risk factors of RIICs report that the development of RIICs is dose and volume dependent. A large volume had been reported to correlate with a high risk of RIICs in several series. 2, 3, 6 In contrast to most studies, a low margin dose was correlated with a high risk of RIICs based on univariate analysis in our series. We believed in most cases that this relationship was due to a low margin dose that was prescribed to a large nidus. This conclusion is supported by the fact that the margin dose was not associated with a high risk of RIICs on multivariate analysis. The fact that margin dose did not affect RIICs is not surprising in our series because great efforts were made in our practice to deliver a dose of 20-25 Gy to the margin of the nidus.
In our analysis, a single drainage vein correlated with a high risk of RIICs. A study from van den Berg et al. 15 also reported that nidi with single draining veins were more common in the group of patients with extensive RIICs than in the group with mild or no RIICs. This evidence further supports the possible role of compromise of draining veins in the development of RIICs.
Several authors extensively investigated the correlation of the dose-volume profile and complications follow- ing radiosurgery for AVMs.
1,3 Flickinger et al. 1 reported that 12-Gy volume correlated with the occurrence of radiosurgery-induced complications. Levegrün et al. 9 reported 8-, 10-, and 12-Gy volume, and mean dose to a specified volume of 16 or 20 cm 3 all served similarly as good predictors of brain edema or breakdown of the blood-brain barrier following radiosurgery for AVMs. Ganz et al. 3 proposed that integral doses differed in patients with or without RIICs and recommended that integral doses could be a simple tool to guide radiosurgical dose prescription to avoid the development of RIICs.
Not surprisingly, nidi that were located in eloquent areas and those that developed extensive RIICs were more likely to be clinically symptomatic. The reason that embolized AVMs were less likely to develop symptomatic RIICs is not entirely clear and warrants further investigation.
Patients undergoing repeated GKS did not have a higher risk of developing RIICs following a repeated treatment, but the incidence of developing moderate to severe imaging changes was higher. The RIICs in our series occurred approximately 13 months after radiosurgery and most of the changes disappeared after a median of 22 months. We did not retreat patients until at least 3 years after the initial treatment, and by the time of repeated radiosurgery the imaging changes after the first radiosurgery had resolved. However, from a radiobiological standpoint, the patients undergoing repeated GKS were different from the patients with only 1 GKS treatment, given that their nidi had been previously irradiated.
Radiation-Induced Imaging Changes and Obliteration of AVM Nidi
Because the goal of GKS for AVMs is a total obliteration of the nidus, we performed a subanalysis to evaluate if the development of RIICs correlates with AVM obliteration. In the present series, 62.8% of nidi that developed RIICs obtained a complete obliteration. Compared with 52.1% of the nidi without RIICs, this difference was statistically significant. In cases with more extensive RIICs, the nidus obliteration rate was higher than that of patients with mild RIICs. A similar observation was reported in a small group of patients treated by van den Berg et al. 15 In their series, obliteration was achieved in 88% of 14 patients with extensive RIICs as compared with 50% of 16 patients without extensive signal changes on MRI following linear accelerator-based radiosurgery for AVMs. It is not clear whether the imaging changes were secondary phenomena of AVM obliteration, or whether the RIICs led to nidi obliteration. We have observed patients who developed extensive RIICs or edema following a premature draining vein closure during the process of AVM obliteration. 22 Based on these observations, we speculate that RIICs might represent a secondary phenomenon of ongoing AVM obliteration, especially in cases with RIICs of vascular origins due to an early arterial or venous occlusion.
Management of RIICs
Corticosteroids have traditionally been used for brain edema or radiation necrosis caused by radiation. All patients with symptomatic RIICs in our series were recommended to receive dexamethasone. Because our patients were managed by their primary care physicians after GKS, we were not able to systematically evaluate the dose and length of corticosteroid usage.
In patients who unsuccessfully undergo corticosteroid treatment, surgery may be required, especially in those who present with persistent increased intracranial pressure or neurological deficits.
11 Massengale et al. 11 reported on 7 patients who underwent resection of symptomatic radiation-injured lesions after radiosurgery for AVMs. Six of these patients benefited from the reversal of neurological deficits and weaning off of corticosteroids. In patients with radiation-injured lesions less than 4 cm, improvement was observed within 2 months. In patients with such lesions measuring 4 cm or more, improvement was observed 9-48 months after resection.
Several new treatments have been tried in small series of patients including pentoxifylline and vitamin E, 19 anticoagulants, 4 and hyperbaric therapy. 18 The success of these alternative treatments is anecdotal, and assessment of their definitive benefits will require a large-scale investigation. A recent randomized double-blind trial of bevacizumab demonstrated its efficacy in the management of CNS radiation necrosis.
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Conclusions
Although considered a minimally invasive procedure and rarely causing acute procedure-related complications, GKS can nevertheless result in delayed adverse effects. In the present series, following 1426 GKS treatments, 33.8% of cases developed RIICs, 8.6% had symptomatic RIICs, and 1.8% had permanent neurological deficits. Several clinical and anatomical factors play a role in the development of RIICs. Patients with a relatively healthy brain and nidi that were large or with single draining veins were 
